Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

258 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients

NCT05153772

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Louisiana State University (LSU) Health Sciences Center - New Orleans Metairie, Louisiana, United States
  • Excel Diagnostics and Nuclear Oncology Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

NCT04291885

Conditions
Adenocarcinoma, Carcinoma, Carcinoma Neuroendocrine Skin, +18 more
Locations
  • Port Macquarie Base Hospital Port Macquarie, New South Wales, Australia
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
  • Melanoma Institute Australia Sydney, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
View all 20 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

NCT03049189

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Banner Health d.b.a. Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Stanford University Stanford, California, United States
  • Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

Combination Immunotherapy in Rare Cancers Under InvesTigation

NCT04969887

Conditions
Advanced Biliary Tract Cancer, Female Reproductive System Neoplasm, Female Urogenital Diseases, +14 more
Locations
  • Border Medical Oncology Unit Albury, New South Wales, Australia
  • Orange Health Service Orange, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
View all 18 locations
View Trial Details
Active, Not Recruiting

Post-Authorization Long-Term Safety Study of LUTATHERA

NCT03691064

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Banner MD Anderson Cancer Center Phoenix, Arizona, United States
  • The Ohio State University Wexner Medical Center Portland, Ohio, United States
  • Oregon Health & Sciences University Hospital Portland, Oregon, United States
  • Virginia Mason in Seattle Seattle, Washington, United States
View all 20 locations
View Trial Details

Related conditions